Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ-positive juvenile dermatomyositis
- PMID: 40221262
- DOI: 10.1016/j.ard.2025.02.002
Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ-positive juvenile dermatomyositis
Conflict of interest statement
Competing interests The authors have no competing interest to disclose in relationship with this manuscript.
Publication types
LinkOut - more resources
Full Text Sources
